Analysis Of Income And Expense [Abstract]

Sopharma Trading AD - Filing #6022496

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Analysis of income and expense [abstract]
Material income and expense [abstract]
Write-downs (reversals of write-downs) of property, plant and equipment [abstract]
Impairment loss recognised in profit or loss, property, plant and equipment
21 611 BGN
2 642 BGN
Finance income (cost)
6 337 BGN
4 383 BGN
Other operating income (expense)
8 903 BGN
8 223 BGN
Expenses by nature [abstract]
Raw materials and consumables used
10 536 BGN
9 042 BGN
Services expense
17 247 BGN
16 039 BGN
Classes of employee benefits expense [abstract]
Employee benefits expense
83 095 BGN
80 841 BGN
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense
29 984 BGN
28 554 BGN
Other expenses, by nature
5 141 BGN
7 541 BGN
Disclosure of attribution of expenses by nature to their function [text block]
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Income tax relating to components of other comprehensive income [abstract]
Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss
- BGN
11,000 BGN
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
- BGN
- BGN
- BGN
- BGN
9 645 BGN
9 574 BGN
71,000 BGN
8,000 BGN
- BGN
- BGN
- BGN
87,000 BGN
7 962 BGN
8 041 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.